These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315 [TBL] [Abstract][Full Text] [Related]
24. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Sprecher CA; Kisiel W; Mathewes S; Foster DC Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3353-7. PubMed ID: 8159751 [TBL] [Abstract][Full Text] [Related]
25. The effect of leukocyte elastase on tissue factor pathway inhibitor. Higuchi DA; Wun TC; Likert KM; Broze GJ Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967 [TBL] [Abstract][Full Text] [Related]
26. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Cunningham AC; Hasty KA; Enghild JJ; Mast AE Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418 [TBL] [Abstract][Full Text] [Related]
27. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Mast AE; Broze GJ Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431 [TBL] [Abstract][Full Text] [Related]
28. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408 [TBL] [Abstract][Full Text] [Related]
29. Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein. Horie S; Hiraishi S; Hamuro T; Kamikubo Y; Matsuda J Thromb Haemost; 2002 Jan; 87(1):80-5. PubMed ID: 11848461 [TBL] [Abstract][Full Text] [Related]
30. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor. Lindhout T; Willems G; Blezer R; Hemker HC Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):131-6. PubMed ID: 8280090 [TBL] [Abstract][Full Text] [Related]
34. The inhibition of human factor Xa by plasminogen activator inhibitor type 1 in the presence of calcium ion, and its enhancement by heparin and vitronectin. Urano T; Ihara H; Takada Y; Nagai N; Takada A Biochim Biophys Acta; 1996 Dec; 1298(2):199-208. PubMed ID: 8980646 [TBL] [Abstract][Full Text] [Related]
35. Factor Xa inhibition by immobilized recombinant tissue factor pathway inhibitor. Chandiwal A; Zaman FS; Mast AE; Hall CL J Biomater Sci Polym Ed; 2006; 17(9):1025-37. PubMed ID: 17094640 [TBL] [Abstract][Full Text] [Related]
36. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures. Schirm S; Liu X; Jennings LL; Jedrzejewski P; Dai Y; Hardy S J Infect Dis; 2009 Jun; 199(12):1807-15. PubMed ID: 19456231 [TBL] [Abstract][Full Text] [Related]
37. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388 [TBL] [Abstract][Full Text] [Related]
38. Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction. Ye Z; Takano R; Hayashi K; Ta TV; Kato H; Kamikubo Y; Nakahara Y; Kumeda K; Hara S Thromb Res; 1998 Mar; 89(6):263-70. PubMed ID: 9669748 [TBL] [Abstract][Full Text] [Related]
39. Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans. Iversen N; Sandset PM; Abildgaard U; Torjesen PA Thromb Res; 1996 Nov; 84(4):267-78. PubMed ID: 8948051 [TBL] [Abstract][Full Text] [Related]
40. Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI). Xu X; Takano R; Nagai Y; Yanagida T; Kamei K; Kato H; Kamikubo Y; Nakahara Y; Kumeda K; Hara S Int J Biol Macromol; 2002 Jun; 30(3-4):151-60. PubMed ID: 12063117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]